CD7 and graft versus host disease: For instance, TCR-deficient allogeneic T cells expressing anti-CD7 CAR could induce remarkable cytotoxicity against CD7-expressing leukemia and lymphoma cells in vivo without graft versus host disease (GvHD) occurrence [240].